Real-World hunt for clues to make vitiligo treatment work better
NCT ID NCT07153666
Summary
This study aims to understand what makes a topical cream called ruxolitinib more or less effective for people with vitiligo, a condition that causes white patches on the skin. Researchers will follow 170 patients in a real-world setting for 24 weeks to see which patient characteristics or factors are linked to better treatment results. The goal is to learn how to use this medication more effectively to help control the skin condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Third Hospital
RECRUITINGBeijing, 100191, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.